Testing effectiveness (Phase 2)UnknownNCT03146650
What this trial is testing
Nivolumab and Ipilimumab in Treating Patients With Metastatic/Recurrent ACC of All Sites and Non-ACC Salivary Gland Cancer
Who this might be right for
Major Salivary Gland CarcinomaMinor Salivary Gland CarcinomaRecurrent Salivary Gland Carcinoma+4 more
Northwestern University 25